DIABNEXT
Paris, France
The DIABNEXT™ team has developed a patented solution innovative and unique compared to the existing monitoring solutions. While the market has focused on mobile apps requiring patients to enter their data by hand, DIABNEXT™ offers a unique solution combining hardware and software to automate the entry in the self-monitoring logbook. Based on several patents, DIABNEXT™ offers a complete solution for monitoring and therapeutic education “doing nothing more” than the actions directly associated with treatment: blood glucose level and insulin injection. The data is accessible to both patients and healthcare professionals who follow them.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- diabnext.com
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of DIABNEXT?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now